SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-047469
Filing Date
2024-05-29
Accepted
2024-05-29 16:20:04
Documents
13
Period of Report
2024-05-29

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0206989-6k_enlivex.htm 6-K 22841
2 SECURITIES PURCHASE AGREEMENT ea020698901ex1-1_enlivex.htm EX-1.1 211603
3 FORM OF SERIES A WARRANT ea020698901ex4-1_enlivex.htm EX-4.1 92285
4 FORM OF SERIES B WARRANT ea020698901ex4-2_enlivex.htm EX-4.2 91552
5 FORM OF PRE-FUNDED WARRANT ea020698901ex4-3_enlivex.htm EX-4.3 87307
6 FORM OF SERIES A PLACEMENT AGENT WARRANT ea020698901ex4-4_enlivex.htm EX-4.4 109501
7 FORM OF SERIES B PLACEMENT AGENT WARRANT ea020698901ex4-5_enlivex.htm EX-4.5 109298
8 OPINION OF FISCHER (FBC & CO.) ea020698901ex5-1_enlivex.htm EX-5.1 13569
9 OPINION OF GREENBERG TRAURIG, LLP ea020698901ex5-2_enlivex.htm EX-5.2 18734
10 PRESS RELEASE ISSUED BY ENLIVEX THERAPEUTICS LTD. ON MAY 29, 2024 ea020698901ex99-1_enlivex.htm EX-99.1 11682
11 GRAPHIC ex5-1_001.jpg GRAPHIC 20541
12 GRAPHIC ex5-2_001.jpg GRAPHIC 7907
13 GRAPHIC ex99-1_001.jpg GRAPHIC 7755
  Complete submission text file 0001213900-24-047469.txt   819936
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616
Enlivex Therapeutics Ltd. (Filer) CIK: 0001596812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36578 | Film No.: 24998690
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)